MedPath
TGA Approval

Irinotecan hydrochloride Injection 300 mg in 15 mL (2) (322682)

322682

Irinotecan hydrochloride Injection 300 mg in 15 mL (2)

Pfizer (Perth) Pty Ltd

September 4, 2019

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

irinotecan hydrochloride trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Irinotecan hydrochloride Injection 300 mg in 15 mL (2) (322682) - TGA 批准文号 | MedPath